Asymptomatic deep vein thrombosis in critically ill COVID-19 patients despite therapeutic levels of anti-Xa activity

Autor: Hugo Rodríguez-Zanella, Claudia Lerma, Sergio Mora-Canela, Victor Manuel Anguiano-Álvarez, Raúl Izaguirre-Ávila, Gustavo Rojas-Velasco, Flavio A Grimaldo-Gómez, Samuel Ramirez-Marroquin, Ángel Ramos-Enríquez, Adriana Torres-Machorro, Edgar García-Cruz, Evelyn Cortina-de la Rosa
Jazyk: angličtina
Rok vydání: 2020
Předmět:
medicine.medical_specialty
Coronavirus disease 2019 (COVID-19)
Deep vein
Letter to the Editors-in-Chief
aPTT
activated partial thromboplastin time
Autopsy
030204 cardiovascular system & hematology
Asymptomatic
VTE
Venous thromboembolism
03 medical and health sciences
0302 clinical medicine
Internal medicine
PT
prothrombin time
medicine
cardiovascular diseases
Prospective cohort study
LDH
Lactate Dehydrogenase
business.industry
Critically ill
HS-CRP
High sensitivity C-Reactive protein
ASA
Acetylsalicylic acid
Hematology
medicine.disease
Thrombosis
LMWH
Low molecular weight heparin
DD
D-Dimer
ADP
adenosine diphosphate
Venous thrombosis
ICU
Intensive care unit
medicine.anatomical_structure
UFH
Unfractionated heparin
030220 oncology & carcinogenesis
medicine.symptom
DVT
Deep vein thrombosis
business
Zdroj: Thrombosis Research
ISSN: 1879-2472
0049-3848
Popis: Highlights • Clinical signs are not useful for detecting DVT in critically ill COVID-19 patients • DVT occurs despite full dose anticoagulation in critically ill COVID-19 patients • Severe COVID-19 patients present a high prevalence of bilateral DVT
Databáze: OpenAIRE
Externí odkaz: